{"entity":{"type":"insider","cik":"0001379010","url":"/insider/0001379010","json_url":"/insider/0001379010.json","name":"ProQuest Management LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":39,"n_filings":4,"first":"2007-08-21","last":"2016-05-16","span_basis":"filed_date"},"name_variants":[{"name":"ProQuest Management LLC","source":"filing","n_filings":4,"first_seen":"2007-08-21","last_seen":"2016-05-16"}],"transactions":[{"id":2058070,"accession":"0000932440-16-000387","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000932440-16-000387","line_url":"/filing/0000932440-16-000387#line-2","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":null,"owner_name":"Moorin Jay; ProQuest Management LLC; ProQuest Associates IV LLC; SCHREIBER ALAIN; ProQuest Investments IV, L.P.","owner_display_name":"Moorin Jay","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock $0,001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13980.0,"shares_display":"13,980","price_per_share":40.92,"price_display":"40.92","price_state":"stated","total_value":572061.6,"total_display":"572,061.60","total_whole":"572,062","shares_owned_after":41081.0,"shares_owned_after_display":"41,081","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-13","filed_date":"2016-05-16","scope":"insider"},{"id":2058067,"accession":"0000932440-16-000387","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000932440-16-000387","line_url":"/filing/0000932440-16-000387#line-1","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":null,"owner_name":"Moorin Jay; ProQuest Management LLC; ProQuest Associates IV LLC; SCHREIBER ALAIN; ProQuest Investments IV, L.P.","owner_display_name":"Moorin Jay","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":5,"other_reporting_owners":4,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":160000.0,"total_display":"160,000.00","total_whole":"160,000","shares_owned_after":55061.0,"shares_owned_after_display":"55,061","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-12","filed_date":"2016-05-16","scope":"insider"},{"id":6837388,"accession":"0001209191-14-012763","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-14-012763","line_url":"/filing/0001209191-14-012763#line-7","is_derivative":false,"issuer_cik":"0000827871","issuer_name":"EAGLE PHARMACEUTICALS, INC.","issuer_ticker":"EGRX","issuer_name_source":null,"issuer_url":"/issuer/0000827871","owner_cik":null,"owner_name":"ProQuest Investments IV, L.P.; ProQuest Associates IV LLC; ProQuest Management LLC","owner_display_name":"ProQuest Investments IV, L.P.","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":3,"other_reporting_owners":2,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":333333.0,"shares_display":"333,333","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":4999995.0,"total_display":"4,999,995.00","total_whole":"4,999,995","shares_owned_after":4770828.0,"shares_owned_after_display":"4,770,828","ownership_form":"I","is_10b5_1":null,"transaction_date":"2014-02-18","filed_date":"2014-02-20","scope":"insider"},{"id":7024671,"accession":"0001209191-07-050044","txn_seq":27,"anchor":"line-27","filing_url":"/filing/0001209191-07-050044","line_url":"/filing/0001209191-07-050044","is_derivative":false,"issuer_cik":"0001033508","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001033508","owner_cik":null,"owner_name":"ProQuest Investments III, L.P.; ProQuest Management LLC; Moorin Jay; SCHREIBER ALAIN","owner_display_name":"ProQuest Investments III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3934.0,"shares_display":"3,934","price_per_share":14.542257244534825,"price_display":"14.54","price_state":"stated","total_value":57209.24,"total_display":"57,209.24","total_whole":"57,209","shares_owned_after":3048665.0,"shares_owned_after_display":"3,048,665","ownership_form":"D","is_10b5_1":null,"transaction_date":"2007-08-21","filed_date":"2007-08-22","scope":"insider","n_lines":5},{"id":7024657,"accession":"0001209191-07-050044","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001209191-07-050044","line_url":"/filing/0001209191-07-050044","is_derivative":false,"issuer_cik":"0001033508","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001033508","owner_cik":null,"owner_name":"ProQuest Investments III, L.P.; ProQuest Management LLC; Moorin Jay; SCHREIBER ALAIN","owner_display_name":"ProQuest Investments III, L.P.","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6100.0,"shares_display":"6,100","price_per_share":14.65862131147541,"price_display":"14.66","price_state":"stated","total_value":89417.59,"total_display":"89,417.59","total_whole":"89,418","shares_owned_after":2750.0,"shares_owned_after_display":"2,750","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-20","filed_date":"2007-08-22","scope":"insider","n_lines":20},{"id":7080697,"accession":"0001209191-07-049779","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001209191-07-049779","line_url":"/filing/0001209191-07-049779","is_derivative":false,"issuer_cik":"0001033508","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001033508","owner_cik":null,"owner_name":"SCHREIBER ALAIN; ProQuest Management LLC; Moorin Jay; ProQuest Investments III, L.P.","owner_display_name":"SCHREIBER ALAIN","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7600.0,"shares_display":"7,600","price_per_share":14.859973684210527,"price_display":"14.86","price_state":"stated","total_value":112935.8,"total_display":"112,935.80","total_whole":"112,936","shares_owned_after":8706.0,"shares_owned_after_display":"8,706","ownership_form":"I","is_10b5_1":null,"transaction_date":"2007-08-17","filed_date":"2007-08-21","scope":"insider","n_lines":11}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000827871","name":"EAGLE PHARMACEUTICALS, INC.","url":"/issuer/0000827871","role":"Ten percent owner","n_filings":2,"first_seen":"2014-02-20","last_seen":"2016-05-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001333248","name":"CADENCE PHARMACEUTICALS INC","url":"/issuer/0001333248","role":"Ten percent owner","n_filings":2,"first_seen":"2007-08-21","last_seen":"2007-08-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001379010","retrieved_at":"2026-08-22T16:16:24+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}